midazolam has been researched along with pyrazines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boehler, M; Bruderer, S; Dingemanse, J; Donazzolo, Y; Juif, PE | 1 |
| Burke, W; Cantarini, M; Frewer, P; Goldwater, R; Han, D; Hara, I; Li, Y; Ren, S; Scarfe, G; Schalkwijk, S; Vishwanathan, K | 1 |
1 trial(s) available for midazolam and pyrazines
| Article | Year |
|---|---|
A pharmacokinetic drug-drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects.
Topics: Acetamides; Adult; Antihypertensive Agents; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Drug Interactions; Half-Life; Healthy Volunteers; Humans; Male; Midazolam; Pyrazines; Young Adult | 2017 |
1 other study(ies) available for midazolam and pyrazines
| Article | Year |
|---|---|
Clinical evaluation of the potential drug-drug interactions of savolitinib: Interaction with rifampicin, itraconazole, famotidine or midazolam.
Topics: Area Under Curve; Cytochrome P-450 CYP3A; Drug Interactions; Famotidine; Humans; Itraconazole; Male; Midazolam; Pyrazines; Rifampin; Triazines | 2022 |